Anuncio
Anuncio
KPTI
Karyopharm Therapeutics Inc.
8.69
USDPatrocinado
+0.52
+6.39%
09 ene, 15:59 UTC -5
Cerrado
Post-mercado
8.68
-0.01
-0.14%
Informes de beneficios de KPTI
Ratio de Sorpresa Positivo
KPTI superó 24 de las últimas 40 estimaciones.
60%
Próximo informe
Fecha del próximo informe
17 feb 2026
Estimate for Q4 25 (Revenue/ EPS)
$36.56M
/-$2.11
Cambio implícito desde Q3 25 (Revenue/ EPS)
-16.99%
/-44.76%
Cambio implícito desde Q4 24 (Revenue/ EPS)
+19.71%
/-41.39%
Karyopharm Therapeutics Inc. earnings per share and revenue
On 03 nov 2025, KPTI reported earnings of -3.82 USD per share (EPS) for Q3 25, missing the estimate of -3.19 USD, resulting in a -19.63% surprise. Revenue reached 44.04 millón, compared to an expected 42.04 millón, with a 4.78% difference. The market reacted with a +4.66% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analistas forecast an EPS of -2.11 USD, with revenue projected to reach 36.56 millón USD, implying an reducir of -44.76% EPS, and reducir of -16.99% in Revenue from the last quarter.
Preguntas frecuentes
What were Karyopharm Therapeutics Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Karyopharm Therapeutics Inc. reported EPS of -$3.82, missing estimates by -19.63%, and revenue of $44.04M, 4.78% above expectations.
How did the market react to Karyopharm Therapeutics Inc.'s Q3 2025 earnings?
The stock price moved up 4.66%, changed from $5.80 before the earnings release to $6.07 the day after.
When is Karyopharm Therapeutics Inc. expected to report next?
The next earning report is scheduled for 17 feb 2026.
What are the forecasts for Karyopharm Therapeutics Inc.'s next earnings report?
Based on 8
analistas, Karyopharm Therapeutics Inc. is expected to report EPS of -$2.11 and revenue of $36.56M for Q4 2025.
Which companies are reporting earnings today?
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio